Previous research on cane toads (Bufo marinus) has documented non-random selection of breeding sites by this invasive species. In the wet-dry tropics of the Northern Territory, toads selected spawning sites in open areas with gently sloping banks and shallow water. If consistent, such biases may present opportunities for toad control via waterbody manipulation -but first we need to know whether such criteria for spawning-site selection (1) are consistent across other parts of the toad's extensive Australian range, and (2) differ from those of native anurans breeding at the same waterbodies. We quantified the attributes of potential and actual spawning-sites in north-eastern New South Wales, in temperate-zone habitat where cane toads have been present for many decades; our study area thus differs in many ways from the previously studied tropical site. We compared habitat and water chemistry variables between 23 cane toad breeding sites and 23 nearby unused sites. To examine habitat use at an even finer scale, we conducted nocturnal surveys of microhabitat use by calling male toads and native anurans. Our results revealed that cane toads in this region were highly selective in their choice of breeding sites, and that the criteria they used in this respect were similar to those used by toads in the Northern Territory. Calling male cane toads also used microhabitats non-randomly within each pond, apparently based on similar criteria to those used when selecting among ponds. Toads differed significantly from native anurans in these respects, suggesting that it may be feasible to manipulate waterbody attributes to impact on invasive toads without disrupting reproduction by native anurans. Breeding-site selection by cane toads (Bufo marinus) and native frogs in northern New South Wales, Australia

For most cancers, the treatment of choice is still being chemotherapy despite of its severe adverse effects, systemic toxicity and limited efficacy due to the development of multidrug resistance (MDR). MDR leads to chemotherapy failure generally associated with a decrease in drug concentration inside cancer cells, frequently due to an overexpression of ABC transporters such as P-glycoprotein (P-gp/MDR1/ABCB1), multidrug resistance-associated proteins (MRPs/ABCCs), and breast cancer resistance protein (BCRP/ABCG2) that limit the efficacy of chemotherapeutic drugs. The aim of this review is to compile information about transcriptional and post-transcriptional regulation of ABC transporters and discuss their role in mediating MDR in cancer cells. This review also focuses on drug resistance by ABC efflux transporters in cancer cells, particularly hepatocellular carcinoma (HCC) and colorectal carcinoma (CRC) cells. Some aspects of the chemotherapy failure and future directions to overcome this problem are also discussed.

No abstract

No abstract